In other countries
The same active substances on other registers, the same brand first.
- Susvimo 100 MG/ML Solucion InyectableSpain · 10 mg · solución inyectable · Roche Registration GmbhSame brand
- SusvimoEuropean Union · Roche Registration GmbHSame brand
- Susvimo 100 mg/ml oplossing voor injectieNetherlands · Oplossing voor injectie · Roche Registration GmbHSame brand
- SusvimoUnited States · 100MG/ML · solution · Genentech INCSame brand
- AmelivuBrazil · Samsung Bioepis br Pharmaceutical ltda.Same substance
- LucentisBrazil · Novartis Biociencias S.ASame substance
- OptinóvisBrazil · Bionovis S.A. - Companhia Brasileira de Biotecnologia FarmaceuticaSame substance
- Lucentis 10 MG/ML Solucion Inyectable en Jeringa PrecargadaSpain · 10 mg/ml · solución inyectable · Novartis Europharm LimitedSame substance
- Ranivisio 10 MG/ML Solucion Inyectable en Jeringa PrecargadaSpain · 10 mg/ml · solución inyectable en jeringa precargada · Midas Pharma GmbhSame substance
- ByoovizEuropean Union · Samsung Bioepis NL B.V.Same substance
- Epruvy (previously Ranibizumab Midas)European Union · Midas Pharma GmbHSame substance
- LucentisCroatiaSame substance
- RimmyrahCroatiaSame substance
- XimluciCroatiaSame substance
- ByoovizItaly · Soluzione iniettabile · Samsung Bioepis NL B.V.Same substance
- EpruvyItaly · Soluzione iniettabile · Midas Pharma GMBHSame substance
- LucentisItaly · Soluzione iniettabile · Novartis Europharm LimitedSame substance
- Byooviz 10 mg/ml, oplossing voor injectieNetherlands · Oplossing voor injectie · Samsung Bioepis NL B.V.Same substance
- Epruvy 10 mg/ml oplossing voor injectieNetherlands · Oplossing voor injectie · Midas Pharma GmbHSame substance
- AnyNew Zealand · Inj 10 mg per ml, 0.3 ml vialSame substance
- AnyNew Zealand · Inj 10 mg per ml, 0.23 ml vialSame substance
- LUCENTIS 10mg/mlRomania · 10mg/ml · sol. inj. · Novartis Europharm LTD.Same substance
- LUCENTIS 10MG-ML INTRAVITREAL InjectionSaudi Arabia · NOVARTIS Pharma Stein AGSame substance
- LUCENTIS 10MG-ML INTRAVITREAL Injection*Saudi Arabia · NovartisSame substance
- Lucentis 10mg/ml Solution for InjectionSingapore · 2.3mg · injection, solution · Novartis (Singapore) Pte LTDSame substance
- LUCENTIS SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 1.65mg/0.165mlSingapore · 1.65mg/0.165ml · injection, solution · Novartis (Singapore) Pte LTDSame substance
- ByoovizUnited States · 10MG/ML · Injection · Samsung Bioepis Co., Ltd.Same substance
- LucentisUnited States · 10MG/ML · Injection · Genentech, Inc.Same substance
Documents
The official texts, at the regulator.
Sources and licences
Compiled by Prognia from the public register below; the register’s text is the official one.
Health Canada, Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada · Added 13 Oct 2026
Report an error or request removalCorrections from the holder or the register are welcome.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Active substance
- Ranibizumab
- Strength
- 100 MG / ML
- Dosage form
- Solution
- Route
- Intravitreal
- Register
- Canada (Health Canada)
- Status
- Authorised
- Status in the register
- Approved
- Registration
- DIN 02530589
- Marketing authorisation holder
- Hoffmann-LA Roche Limited
- ATC code
- S01LA04
- Group
- Sensory organs
- Supply
- PRESCRIPTION, SCHEDULE D